HAT1
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for HAT1, covering 2017-02-23 to 2019-02-21. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis [Phase 2]